Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van der Flier

Showing results (291-300 of 791) with videos related to

Pageof 80
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 5, 2025
How can Alzheimer's disease blood-based biomarkers reach clinical practice?Robert Perneczky, Frances-Catherine Quevenco, James Hendrix, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 22, 2022
Precision estimates of relative and absolute cerebral blood flow in Alzheimer's disease and cognitively normal individualsFiona Heeman, Denise Visser, Maqsood Yaqub, et al.
Alzheimer'S Research & Therapy|November 28, 2023
Clinical outcomes up to 9 years after [<sup>18</sup>F]flutemetamol amyloid-PET in a symptomatic memory clinic populationLyduine E Collij, Gill Farrar, Marissa Zwan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2010
Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET imagesNelleke Tolboom, Wiesje M van der Flier, Jolanda Boverhoff, et al.
Dementia and Geriatric Cognitive Disorders|September 25, 2009
Carotid and basilar artery wall shear stress in Alzheimer's disease and mild cognitive impairmentA C G M van Es, W M van der Flier, F M A Box, et al.
Alzheimer'S Research & Therapy|January 5, 2021
Four subgroups based on tau levels in Alzheimer's disease observed in two independent cohortsFlora H Duits, Kirsten E J Wesenhagen, Laura Ekblad, et al.
Journal of Hypertension|August 17, 2023
Orthostatic hypotension and its association with cerebral small vessel disease in a memory clinic populationJulia H I Wiersinga, Hanneke F M Rhodius-Meester, Frank J Wolters, et al.
The Lancet. Healthy Longevity|September 13, 2022
Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort studyInge M W Verberk, Malika B Laarhuis, Karlijn A van den Bosch, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 17, 2012
No evidence for additional blood-brain barrier P-glycoprotein dysfunction in Alzheimer's disease patients with microbleedsDaniëlle M E van Assema, Jeroen D C Goos, Wiesje M van der Flier, et al.
JAMA Neurology|September 15, 2015
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer DiseaseMaartje I Kester, Charlotte E Teunissen, Daniel L Crimmins, et al.
Pageof 80

Showing results (291-300 of 791) with videos related to

Sort By:
Pageof 80
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 5, 2025
How can Alzheimer's disease blood-based biomarkers reach clinical practice?Robert Perneczky, Frances-Catherine Quevenco, James Hendrix, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 22, 2022
Precision estimates of relative and absolute cerebral blood flow in Alzheimer's disease and cognitively normal individualsFiona Heeman, Denise Visser, Maqsood Yaqub, et al.
Alzheimer'S Research & Therapy|November 28, 2023
Clinical outcomes up to 9 years after [<sup>18</sup>F]flutemetamol amyloid-PET in a symptomatic memory clinic populationLyduine E Collij, Gill Farrar, Marissa Zwan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2010
Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET imagesNelleke Tolboom, Wiesje M van der Flier, Jolanda Boverhoff, et al.
Dementia and Geriatric Cognitive Disorders|September 25, 2009
Carotid and basilar artery wall shear stress in Alzheimer's disease and mild cognitive impairmentA C G M van Es, W M van der Flier, F M A Box, et al.
Alzheimer'S Research & Therapy|January 5, 2021
Four subgroups based on tau levels in Alzheimer's disease observed in two independent cohortsFlora H Duits, Kirsten E J Wesenhagen, Laura Ekblad, et al.
Journal of Hypertension|August 17, 2023
Orthostatic hypotension and its association with cerebral small vessel disease in a memory clinic populationJulia H I Wiersinga, Hanneke F M Rhodius-Meester, Frank J Wolters, et al.
The Lancet. Healthy Longevity|September 13, 2022
Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort studyInge M W Verberk, Malika B Laarhuis, Karlijn A van den Bosch, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 17, 2012
No evidence for additional blood-brain barrier P-glycoprotein dysfunction in Alzheimer's disease patients with microbleedsDaniëlle M E van Assema, Jeroen D C Goos, Wiesje M van der Flier, et al.
JAMA Neurology|September 15, 2015
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer DiseaseMaartje I Kester, Charlotte E Teunissen, Daniel L Crimmins, et al.
Pageof 80